Sanzyme Biologics Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 10-07-2024
- Paid Up Capital ₹ 1.67 Cr
as on 10-07-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.50 Cr
as on 10-07-2024
- Revenue -9.75%
(FY 2023)
- Profit -40.91%
(FY 2023)
- Ebitda -46.33%
(FY 2023)
- Net Worth 12.63%
(FY 2023)
- Total Assets 10.03%
(FY 2023)
About Sanzyme Biologics
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.67 Cr.
The company has closed loans amounting to ₹6.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanzyme Biologics Private Limited India is Dhruv Soman as CEO. Jay Soman, Surapaneni Rao, Raunak Soman, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110TG2016PTC112002
- Company No.
112002
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Sep 2016
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sanzyme Biologics Private Limited offer?
Sanzyme Biologics Private Limited offers a wide range of products and services, including Industrial Valves & Valve Fittings, Globe Valves, Nutraceuticals & Dietary Supplements, Dietary Supplements, Pumps, Pumping Machines & Spares, Process Pumps, Water Pumps, Electric Pump, Butterfly Valves, Air Valves.
Who are the key members and board of directors at Sanzyme Biologics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhruv Soman | CEO | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raunak Soman  | Whole-Time Director | 21-Oct-2017 | Current |
| Jay Soman | Director | 16-Sep-2016 | Current |
| Surapaneni Rao | Director | 16-Sep-2016 | Current |
| Dhruv Soman | Whole-Time Director | 21-Oct-2017 | Current |
Financial Performance and Corporate Structure Insights of Sanzyme Biologics.
Sanzyme Biologics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.75% decrease. The company also saw a substantial fall in profitability, with a 40.91% decrease in profit. The company's net worth Soared by an impressive increase of 12.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanzyme Biologics?
In 2023, Sanzyme Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sanzyme Private LimitedActive 55 years 4 monthsJay Soman, Surapaneni Rao and 2 more are mutual person
Pridhvi Asset Reconstruction And Securitisation Company LimitedActive 17 years 8 monthsSurapaneni Rao is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Apr 2018 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Sanzyme Biologics?
Sanzyme Biologics has a workforce of 303 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanzyme Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanzyme Biologics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
